DGFT implements stricter regulations for export of chitin and chitosan derivatives
In a move aimed at enhancing compliance and facilitating smoother trade operations, the Directorate General of Foreign Trade (DGFT) has introduced stringent policy conditions for the export of chitin and chitosan derivatives. These measures are specifically tailored to ensure regulatory compliance, particularly for exports destined for the EU market, thereby bolstering the reputation of Indian exports globally.
This notification aims to streamline the export process for chitin, chitosan, and their derivatives while ensuring compliance with regulatory standards, particularly for exports to the EU. The implementation of these policy conditions will facilitate smoother trade operations and enhance the credibility of Indian exports in the global market.
Chitosan is used as an excipient in pharmaceutical formulations and in biomedical applications including wound dressings. Chitosan derivatives have important orthopedic and tissue engineering applications. Chitosan is a derivative of chitin, extracted from the exoskeleton of crustaceans, including shrimp, lobster, and clams, and from the cell wall of reishi mushrooms.
Chitosan has potent antimicrobial properties, making it useful for antimicrobial agents in medical treatments. Chitosan can significantly impact regenerative technology, for example, cornea, skin and cardiac regenerative technologies among others.
The notification, effective immediately, incorporates policy conditions for exports falling under ITC HS code 39139090. While the export of these products is generally ‘Free,’ exports to the European Union (EU) are now subject to specific conditions.
“Exporters must obtain a ‘Shipment Clearance Certificate’ issued consignment-wise by the CAPEXIL, indicating various details such as the exporter’s information, IEC No., product details, quantity, invoice number, port of loading, and destination,” informed Santosh Kumar Sarangi, director general of Foreign Trade.
Furthermore, exporters are required to provide a ‘Health Certificate’ to the buyer, jointly issued by CAPEXIL and the regional animal quarantine officer, department of animal husbandry, dairying and fisheries, ministry of agriculture and farmers welfare, Government of India. This certificate should include information on the product, packaging, origin, destination, vessel details, and health requirements.
For further information and clarifications, exporters are encouraged to reach out to the Directorate General of Foreign Trade at dgft@nic.in.
CAPEXIL, Premier Export Promotion Council, was set up in March 1958 by the Ministry of Commerce, Government of India to promote export of chemical and allied products from India. And since then has been the voice of the Indian business community. With the headquarters at Kolkata, and regional offices at New Delhi, Mumbai, Kolkata and Chennai, CAPEXIL has more than 4,500 members across the country. One of the fascinating aspects of CAPEXIL is the overwhelming variety of products it deals with.
CAPEXIL is an ardent advocate of exporters to the government and the primary focus is to provide export assistance to its member exporters.
CAPEXIL sends trade delegations to all major and developing markets around the world, showcases Indian exports all over the world through exhibitions, fairs. CAPEXIL can help the sourcing needs of an importer anywhere in the world, and also the selling needs of Indian exporters.
Source : 1
AuroBlog | Clinical Research Blog | Aurous HealthCare CRO, India 